General Information
Version
6.13
Revision date
2026-08-19
Product name
Duolink flowPLA Detection Kit - Violet
Emergency telephone
+81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334, H411
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H411 Toxic to aquatic life with long lasting effects. EUH430 May cause endocrine disruption in the environment. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. EUH430 May cause endocrine disruption in the environment.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Response
P391 Collect spillage.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Ligase (1U/µL), 30RXN Polymerase (10U/µL), 30RXN Reduced Labelling (<= 125 ml)
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
This substance/mixture contains components considered to have endocrine disrupting properties for environment , according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Respiratory sensitisation, Category H334: May cause allergy or asthma 1 symptoms or breathing difficulties if inhaled. Long-term (chronic) aquatic hazard, H411: Toxic to aquatic life with long lasting Category 2 effects. Endocrine disruptor for EUH430: May cause endocrine disruption in environment, Category 1 the environment.